| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |